SGMS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.708000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.016400E-01
Normal-vs-Stage2
3.658800E-01
Normal-vs-Stage3
6.894000E-01
Normal-vs-Stage4
3.421700E-02
Stage1-vs-Stage2
7.418800E-01
Stage1-vs-Stage3
3.406400E-01
Stage1-vs-Stage4
7.704200E-02
Stage2-vs-Stage3
2.679800E-02
Stage2-vs-Stage4
2.843400E-01
Stage3-vs-Stage4
1.458280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.956790E-01
Normal-vs-AfricanAmerican
2.789200E-01
Normal-vs-Asian
3.204600E-01
Caucasian-vs-AfricanAmerican
3.722000E-01
Caucasian-vs-Asian
4.642400E-01
AfricanAmerican-vs-Asian
3.414200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.540400E-01
Normal-vs-Female
1.818980E-01
Male-vs-Female
8.202800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.202800E-01
Normal-vs-Age(41-60Yrs)
3.441600E-01
Normal-vs-Age(61-80Yrs)
2.681400E-01
Normal-vs-Age(81-100Yrs)
3.116800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.266000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.796200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.890800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.921800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.022300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.980200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.770800E-01
Normal-vs-Daily Drinker
4.276000E-01
Normal-vs-Weekly Drinker
2.588400E-01
Normal-vs-Occasional Drinker
1.746010E-01
Normal-vs-Social Drinker
1.599040E-01
Non Drinker-vs-Daily Drinker
8.870200E-01
Non Drinker-vs-Weekly Drinker
3.634600E-01
Non Drinker-vs-Occasional Drinker
5.036300E-02
Non Drinker-vs-Social Drinker
9.450100E-02
Daily Drinker-vs-Weekly Drinker
4.001000E-01
Daily Drinker-vs-Occasional Drinker
5.369900E-02
Daily Drinker-vs-Social Drinker
1.411370E-01
Weekly Drinker-vs-Occasional Drinker
2.557600E-01
Weekly Drinker-vs-Social Drinker
5.831400E-01
Occasional Drinker-vs-Social Drinker
4.772400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.733000E-01
Normal-vs-Grade 2
4.591700E-02
Normal-vs-Grade 3
4.983600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.950200E-01
Grade 1-vs-Grade 3
9.617600E-01
Grade 1-vs-Grade 4
5.733000E-01
Grade 2-vs-Grade 3
8.767800E-01
Grade 2-vs-Grade 4
4.591700E-02
Grade 3-vs-Grade 4
4.983600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.159600E-01
Normal-vs-NonDiabetic
1.970030E-01
Diabetic-vs-NonDiabetic
4.891200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.934370E-01
Normal-vs-NoPancreatitis
2.170600E-01
Pancreatitis-vs-NoPancreatitis
7.190200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.855000E-01
Normal-vs-N1
3.823000E-01
N0-vs-N1
3.712000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.638600E-01
Normal-vs-TP53-NonMutant
3.658200E-01
TP53-Mutant-vs-TP53-NonMutant
2.514000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
